Table 1.
Patient | Gender | Age (year) | Performance (ECOG) | Pancreatic Primary | Clinical TN-stage | SUVmax |
1 | Male | 63 | 2 | Head | T4N0 | 9.8 |
2 | Male | 61 | 1 | Head | T4N1 | 10.9 |
3 | Male | 54 | 1 | Head | T4N1 | 11.3 |
4 | Female | 65 | 1 | Body | T4N1 | 19.2 |
5 | Male | 48 | 0 | Head | T4N0 | 14.7 |
6 | Male | 52 | 0 | Body | T4N1 | 8.8 |
7 | Female | 59 | 2 | Head | T4N0 | 7.9 |
8 | Male | 57 | 1 | Head | T4N1 | 10.4 |
9 | Male | 46 | 1 | Head | T4N1 | 17.6 |
10 | Male | 51 | 0 | Head | T4N0 | 15.3 |
11 | Male | 58 | 0 | Body | T4N1 | 8.6 |
12 | Female | 62 | 1 | Head | T4N1 | 9.3 |
13 | Male | 43 | 1 | Body | T4N0 | 11.5 |
14 | Male | 55 | 2 | Head | T4N1 | 15.8 |
Abbreviations: ECOG = Eastern Cooperative Oncology Group; SUVmax = Maximum standard uptake value